Oxygen Therapy in Patients With Acute Heart Failure: Friend or Foe?

JACC: Heart Failure

Volumn 4, Issue 10, 2016, Pages 783-790

  Sepehrvand, Nariman ^a   Ezekowitz, Justin A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

acute heart failure; hyperoxia; oxygen; supplemental

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ARTERIAL OXYGEN TENSION; BRAIN BLOOD VESSEL; CARDIOVASCULAR EFFECT; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; COST EFFECTIVENESS ANALYSIS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPEROXIA; OXIDATIVE STRESS; OXYGEN SATURATION; OXYGEN THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; VASOCONSTRICTION; ACUTE DISEASE; CARDIAC MUSCLE; COMPLICATION; ETIOLOGY; HEART FAILURE; HEMODYNAMICS; HYPOXIA; METABOLISM; OXYGEN CONSUMPTION; PROCEDURES;

ACUTE DISEASE; CORONARY CIRCULATION; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPEROXIA; HYPOXIA; MYOCARDIUM; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY; REACTIVE OXYGEN SPECIES; VASOCONSTRICTION;

EID: 84991584294     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2016.03.026     Document Type: Review

References (60)

1. 1 Ezekowitz, J.A., Kaul, P., Bakal, J.A., Quan, H., McAlister, F.A., Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?. Eur J Heart Fail 13 (2011), 142–147.
2. 2 Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
3. 3 Gray, A., Goodacre, S., Newby, D.E., Masson, M., Sampson, F., Nicholl, J., Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 359 (2008), 142–151.
4. 4 Vital, F.M., Ladeira, M.T., Atallah, A.N., Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev, 2013 (5):CD005351.
5. 5 Steele, C., Severe angina pectoris relieved by oxygen inhalations. BMJ, 2, 1900, 1568.
6. 6 Ezekowitz, J.A., Hernandez, A.F., O'Connor, C.M., et al. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol 59 (2012), 1441–1448.
7. 7 McKelvie, R.S., Moe, G.W., Ezekowitz, J.A., et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 29 (2013), 168–181.
8. 8 McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14 (2012), 803–869.
9. 9 Lindenfeld, J., Albert, N.M., Boehmer, J.P., et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16 (2010), e1–e194.
10. 10 Mahler, D.A., Selecky, P.A., Harrod, C.G., et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest 137 (2010), 674–691.
11. 11 McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
12. 12 O'Driscoll, B.R., Howard, L.S., Davison, A.G., BTS guideline for emergency oxygen use in adult patients. Thorax 63:Suppl 6 (2008), vi1–vi68.
13. 13 Field, J.M., Hazinski, M.F., Sayre, M.R., et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122 (2010), S640–S656.
14. 14 Mak, S., Azevedo, E.R., Liu, P.P., Newton, G.E., Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 120 (2001), 467–473.
15. 15 Park, J.H., Balmain, S., Berry, C., Morton, J.J., McMurray, J.J., Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 96 (2010), 533–538.
16. 16 Haque, W.A., Boehmer, J., Clemson, B.S., Leuenberger, U.A., Silber, D.H., Sinoway, L.I., Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 27 (1996), 353–357.
17. 17 Farquhar, H., Weatherall, M., Wijesinghe, M., et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 158 (2009), 371–377.
18. 18 Cabello, J.B., Burls, A., Emparanza, J.I., Bayliss, S., Quinn, T., Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev, 2013 (8):CD007160.
19. 19 Stub, D., Smith, K., Bernard, S., et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Versus Oxygen in Myocardial Infarction Study (AVOID study). Am Heart J 163 (2012), 339–345.
20. 20 Stub, D., Smith, K., Bernard, S., et al. Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 131 (2015), 2143–2150.
21. 21 Hofmann, R., James, S.K., Svensson, L., et al. Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction trial. Am Heart J 167 (2014), 322–328.
22. 22 Gore, A., Muralidhar, M., Espey, M.G., Degenhardt, K., Mantell, L.L., Hyperoxia sensing: from molecular mechanisms to significance in disease. J Immunotoxicol 7 (2010), 239–254.
23. 23 Nagato, A.C., Bezerra, F.S., Lanzetti, M., et al. Time course of inflammation, oxidative stress and tissue damage induced by hyperoxia in mouse lungs. Int J Exp Pathol 93 (2012), 269–278.
24. 24 Rodriguez-Gonzalez, R., Martin-Barrasa, J.L., Ramos-Nuez, A., et al. Multiple system organ response induced by hyperoxia in a clinically relevant animal model of sepsis. Shock 42 (2014), 148–153.
25. 25 Thiel, M., Chouker, A., Ohta, A., et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol, 3, 2005, e174.
26. 26 Hou, L., Xie, K., Qin, M., et al. Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice. Shock 33 (2010), 646–654.
27. 27 Waisman, D., Brod, V., Wolff, R., et al. Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion. Am J Physiol Heart Circ Physiol 285 (2003), H643–H652.
28. 28 Carvalho, C.R., de Paula Pinto Schettino, G., Maranhao, B., Bethlem, E.P., Hyperoxia and lung disease. Curr Opin Pulm Med 4 (1998), 300–304.
29. 29 Lukkarinen, H.P., Laine, J., Kaapa, P.O., Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. Pediatr Res 53 (2003), 254–259.
30. 30 Jezek, P., Hlavata, L., Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37 (2005), 2478–2503.
31. 31 Carnesecchi, S., Deffert, C., Pagano, A., et al. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med 180 (2009), 972–981.
32. 32 Mittal, M., Roth, M., Konig, P., et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101 (2007), 258–267.
33. 33 Kulkarni, A.C., Kuppusamy, P., Parinandi, N., Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid Redox Signal 9 (2007), 1717–1730.
34. 34 Mouren, S., Souktani, R., Beaussier, M., et al. Mechanisms of coronary vasoconstriction induced by high arterial oxygen tension. Am J Physiol 272 (1997), H67–H75.
35. 2+ channels. Am J Physiol 274 (1998), H2018–H2024.
36. 36 Sjoberg, F., Singer, M., The medical use of oxygen: a time for critical reappraisal. J Intern Med 274 (2013), 505–528.
37. 37 Mak, S., Egri, Z., Tanna, G., Colman, R., Newton, G.E., Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation. Am J Physiol Heart Circ Physiol 282 (2002), H2414–H2421.
38. 38 Floyd, T.F., Clark, J.M., Gelfand, R., et al. Independent cerebral vasoconstrictive effects of hyperoxia and accompanying arterial hypocapnia at 1 ATA. J Appl Physiol (1985) 95 (2003), 2453–2461.
39. 2 much of a good thing?. Crit Care, 15, 2011, 305.
40. 40 Andreas, S., Bingeli, C., Mohacsi, P., Luscher, T.F., Noll, G., Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 123 (2003), 366–371.
41. 41 Daly, W.J., Bondurant, S., Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men—resting, with reactive hyperemia, and after atropine. J Clin Invest 41 (1962), 126–132.
42. 42 Saadjian, A., Paganelli, F., Levy, S., Hemodynamic response to oxygen administration in chronic heart failure: role of chemoreflexes. J Cardiovasc Pharmacol 33 (1999), 144–150.
43. 43 Spoelstra-de Man, A.M., Smit, B., Oudemans-van Straaten, H.M., Smulders, Y.M., Cardiovascular effects of hyperoxia during and after cardiac surgery. Anaesthesia 70 (2015), 1307–1319.
44. 44 Saugstad, O.D., Resuscitation of newborn infants: from oxygen to room air. Lancet 376 (2010), 1970–1971.
45. 45 Felker, G.M., Lee, K.L., Bull, D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
46. 46 Claure, N., Bancalari, E., Automated closed loop control of inspired oxygen concentration. Respir Care 58 (2013), 151–161.
47. 47 Lellouche, F., L'Her, E., Automated oxygen flow titration to maintain constant oxygenation. Respir Care 57 (2012), 1254–1262.
48. 48 Jessup, M., Abraham, W.T., Casey, D.E., et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53 (2009), 1343–1382.
49. 49 Dworzynski, K., Roberts, E., Ludman, A., Mant, J., Diagnosing and managing acute heart failure in adults: summary of NICE guidance. BMJ, 349, 2014 g5695.
50. 50 National Institute for Health and Care Excellence. Acute heart failure: diagnosing and managing acute heart failure in adults (Clinical Guideline CG187). 2014, National Institute for Health and Care Excellence, London, United Kingdom.
51. 51 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. 2011, National Heart Foundation of Australia, Canberra.
52. 52 Bourassa, M.G., Campeau, L., Bois, M.A., Rico, O., The effects of inhalation of 100 percent oxygen on myocardial lactate metabolism in coronary heart disease. Am J Cardiol 24 (1969), 172–177.
53. 53 Ganz, W., Donoso, R., Marcus, H., Swan, H.J., Coronary hemodynamics and myocardial oxygen metabolism during oxygen breathing in patients with and without coronary artery disease. Circulation 45 (1972), 763–768.
54. 54 Rawles, J.M., Kenmure, A.C., Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J 1 (1976), 1121–1123.
55. 55 Wilson, A.T., Channer, K.S., Hypoxaemia and supplemental oxygen therapy in the first 24 hours after myocardial infarction: the role of pulse oximetry. J R Coll Physicians Lond 31 (1997), 657–661.
56. 56 Ukholkina, G.B., Kostianov, I., Kuchkina, N.V., Grendo, E.P., Gofman, IaB., [Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction]. Kardiologiia, 45, 2005, 59.
57. 57 McNulty, P.H., King, N., Scott, S., et al. Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol 288 (2005), H1057–H1062.
58. 58 McNulty, P.H., Robertson, B.J., Tulli, M.A., et al. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol (1985) 102 (2007), 2040–2045.
59. 59 Ranchord, A.M., Argyle, R., Beynon, R., et al. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am Heart J 163 (2012), 168–175.
60. 60 Khoshnood, A., Carlsson, M., Akbarzadeh, M., et al. The effects of oxygen therapy on myocardial salvage in ST elevation myocardial infarction treated with acute percutaneous coronary intervention: the Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) study. Cardiology 132 (2015), 16–21.